주사 용수 시장 보고서(2026년)
Water For Injection Global Market Report 2026
상품코드 : 1948639
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,777,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,796,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,815,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

주사 용수 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 304억 5,000만 달러에서 2026년에는 333억 8,000만 달러에 이르고, CAGR 9.6%로 성장할 전망입니다. 지난 수년간의 성장 요인으로는 정제수 제조 기술의 제한적인 보급, 주사제 제형 증가, 병원 및 헬스케어 인프라 확충, 엄격한 약전 규제, 단일 지역에 대한 제조 거점 의존도 등을 꼽을 수 있습니다.

주사 용수 시장 규모는 향후 몇 년간 강력한 성장이 전망되고 있습니다. 2030년에는 476억 3,000만 달러에 이르고, CAGR은 9.3%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 증류 및 멤브레인 기반 공정의 기술 발전, 의약품 생산 능력에 대한 투자 증가, 생물학적 제제 및 백신 생산 확대, 위탁연구개발 및 제조 기관(CRAMO)의 확대, 자동화 및 스마트 제조 솔루션 도입 등이 있습니다. 예측 기간 동안 주요 동향으로는 주사제용 고순도 물 수요 증가, 고도의 멸균 및 여과 기술 채택, 규제 준수 및 품질 기준 강화, 제약 및 생명공학 제조 확대, 연구 및 실험용 주사제용 물의 사용 확대 등이 있습니다.

당뇨병 유병률 증가는 향후 몇 년 동안 주사용수 시장의 성장을 견인할 것으로 예측됩니다. 당뇨병은 인슐린 분비 부족 또는 인슐린 작용 장애로 인해 신체가 혈당을 적절히 조절하지 못하는 만성 질환입니다. 이러한 당뇨병 환자 증가는 주로 전 세계 비만율 증가와 관련이 있습니다. 과도한 체지방은 인슐린의 효과적인 활용을 방해하여 혈당 조절을 방해하고 당뇨병 발병 위험을 증가시킵니다. 주사용 물은 인슐린과 같은 주사제를 재구성하거나 희석하기 위해 당뇨병 치료에 자주 사용되며, 이러한 약물을 안전하게 투여하고 무균 상태를 유지하여 효능을 유지하고 감염을 방지합니다. 예를 들어, 2025년 2월 영국에 기반을 둔 의료 전문가를 위한 개별 학습 플랫폼 'Health Professional Academy'는 영국 내 당뇨병 진단자 수가 전년도 440만 명에서 460만 명으로 사상 최고치를 기록했다고 보고했습니다. 그 결과, 당뇨병 유병률 증가는 주사용수 시장의 확대를 뒷받침하고 있습니다.

주사용수 시장의 주요 기업들은 규제 요건을 충족시키면서 에너지 소비와 운영 비용을 줄이기 위해 냉수 주사용수 시스템과 같은 첨단 기술을 개발하고 있습니다. 냉수 주사용수 기술은 상온에서 멤브레인 기반 정수를 통해 주사용수를 생산할 수 있으며, 기존의 증류 공정을 거치지 않고도 약전 기준을 준수합니다. 예를 들어, 2024년 12월 인도 제약회사 CN 워터시스템즈(CN Water Systems)는 기존 증류법에 비해 에너지 사용량과 운영비용을 크게 절감하는 'OSMOTRON 콜드/주입용수(WFI)' 기술을 출시하였습니다. 이 시스템은 연수화나 탈염소 처리가 필요 없고, 삼중막 배리어를 채택하여 안전성과 효율성을 높이며, 식수에서 직접 WFI를 생성합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

Water for injection is sterile, highly purified water specifically designed for preparing parenteral (injectable) medications, where contaminants-including pyrogens-must be strictly eliminated. It is commonly produced through methods like distillation or reverse osmosis and must meet rigorous pharmaceutical quality standards to ensure safety for intravenous use.

The primary categories of water for injection include single-distilled water for injection, double-distilled water for injection, sterile water for injection, and purified water for injection. Single-distilled water for injection is produced by distilling water once to remove impurities and microorganisms. It is available in various packaging options, such as vials, ampules, bottles, drums, and bulk containers, and is manufactured using processes like distillation and membrane-based reverse osmosis. This type of water for injection is used in multiple applications, including as solvents and diluents, in culture media, for equipment cleaning, and more, serving a range of end users such as pharmaceutical and biotechnology firms, hospitals and healthcare facilities, contract research and manufacturing organizations, among others.

Tariffs have influenced the water for injection market by increasing the cost of imported production equipment and filtration membranes, leading to higher production expenses for manufacturers. Segments such as membrane-based reverse osmosis systems and bulk packaging containers are particularly affected, with Asia-Pacific regions like China and India facing significant cost pressures due to import duties. While tariffs create supply chain challenges and regional price fluctuations, they also encourage local production and innovation in manufacturing processes, which can enhance domestic capabilities and long-term market resilience.

The water for injection market research report is one of a series of new reports from The Business Research Company that provides water for injection market statistics, including water for injection industry global market size, regional shares, competitors with a water for injection market share, detailed water for injection market segments, market trends and opportunities, and any further data you may need to thrive in the water for injection industry. This water for injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The water for injection market size has grown strongly in recent years. It will grow from $30.45 billion in 2025 to $33.38 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to limited availability of purified water production technologies, growing injectable drug formulations, increasing hospital and healthcare infrastructure, stringent pharmacopeial regulations, reliance on single-region manufacturing hubs.

The water for injection market size is expected to see strong growth in the next few years. It will grow to $47.63 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to technological advancements in distillation and membrane-based processes, rising investment in pharmaceutical manufacturing capacity, growing biologics and vaccine production, expansion of contract research and manufacturing organizations (cramos), adoption of automation and smart manufacturing solutions. Major trends in the forecast period include increasing demand for high-purity water in injectable drugs, adoption of advanced sterilization and filtration techniques, rising regulatory compliance and quality standards, expansion of pharmaceutical and biotechnology manufacturing, growing use of water for injection in research and laboratory applications.

The rising prevalence of diabetes is expected to drive the growth of the water for injection market in the coming years. Diabetes is a chronic condition where the body cannot properly regulate blood sugar (glucose) levels, either due to inadequate insulin production or ineffective insulin use. This increase in diabetes cases is largely linked to the global rise in obesity, as excess body fat impairs the body's ability to use insulin effectively, leading to poor blood sugar control and a higher risk of developing the disease. Water for injection is frequently used in diabetes care to reconstitute or dilute injectable medications like insulin, ensuring these drugs are administered safely and sterility is maintained to preserve their effectiveness and prevent infections. For example, in February 2025, the Health Professional Academy, a UK-based personalized health professional learning platform, reported that the number of people diagnosed with diabetes in the UK reached a record 4.6 million, up from 4.4 million the previous year. Consequently, the growing prevalence of diabetes is supporting the expansion of the water for injection market.

Leading companies in the water for injection market are developing advanced technologies, such as cold water for injection systems, to lower energy consumption and operational costs while meeting regulatory requirements. Cold water for injection technology involves producing water for injection using membrane-based purification at ambient temperatures, removing the need for traditional distillation but still complying with pharmacopeial standards. For instance, in December 2024, CN Water Systems Pvt. Ltd., an India-based pharmaceutical firm, launched its OSMOTRON Cold/Ambient Water for Injection (WFI) technology, which substantially cuts energy use and operational expenses compared to conventional distillation. This system produces WFI directly from potable water without requiring water softening or dechlorination, employing a triple-membrane barrier to enhance safety and efficiency.

In March 2023, Milla Pharmaceuticals Inc., a US-based developer and marketer of generic prescription drugs, partnered with Athenex Pharmaceutical Division LLC to introduce a generic magnesium sulfate product in water for injection. This collaboration focuses on developing and launching a high-quality, cost-effective generic magnesium sulfate in water for injection, packaged in non-PVC, single-patient-use containers. This approach aims to improve patient safety, minimize contamination risks, and enhance accessibility of this critical medication to healthcare providers and patients worldwide. Athenex Pharmaceutical Division LLC is a US-based specialty oncology pharmaceutical company that produces generic magnesium sulfate in water for injection.

Major companies operating in the water for injection market are Pfizer Inc., Veolia Water Technologies Inc., Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Eli Lilly and Co., Boehringer Ingelheim, Amgen Inc., Merck KGaA, Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd., Sandoz International GmbH, Baxter International Inc., B. Braun Melsungen AG, Lonza Group AG, Apotex Inc., BWT AG, Sartorius AG, Wuxi Biologics Cayman Inc., ICU Medical Inc., Evoqua Water Technologies, Cambrex Corporation.

North America was the largest region in the water for injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the water for injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the water for injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The water for injection market consists of sales of injectable drugs, irrigation solutions, infusion fluids, ophthalmic solutions, inhalation solutions, and wound care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Water For Injection Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses water for injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for water for injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The water for injection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Water For Injection Market Characteristics

3. Water For Injection Market Supply Chain Analysis

4. Global Water For Injection Market Trends And Strategies

5. Water For Injection Market Analysis Of End Use Industries

6. Water For Injection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Water For Injection Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Water For Injection Total Addressable Market (TAM) Analysis for the Market

9. Water For Injection Market Segmentation

10. Water For Injection Market Regional And Country Analysis

11. Asia-Pacific Water For Injection Market

12. China Water For Injection Market

13. India Water For Injection Market

14. Japan Water For Injection Market

15. Australia Water For Injection Market

16. Indonesia Water For Injection Market

17. South Korea Water For Injection Market

18. Taiwan Water For Injection Market

19. South East Asia Water For Injection Market

20. Western Europe Water For Injection Market

21. UK Water For Injection Market

22. Germany Water For Injection Market

23. France Water For Injection Market

24. Italy Water For Injection Market

25. Spain Water For Injection Market

26. Eastern Europe Water For Injection Market

27. Russia Water For Injection Market

28. North America Water For Injection Market

29. USA Water For Injection Market

30. Canada Water For Injection Market

31. South America Water For Injection Market

32. Brazil Water For Injection Market

33. Middle East Water For Injection Market

34. Africa Water For Injection Market

35. Water For Injection Market Regulatory and Investment Landscape

36. Water For Injection Market Competitive Landscape And Company Profiles

37. Water For Injection Market Other Major And Innovative Companies

38. Global Water For Injection Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Water For Injection Market

40. Water For Injection Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기